Given the success of the previous collection
Association of Novel Anthropometric Indexes with Metabolic Syndrome and the new advances in the field, we are pleased to announce the launch of Volume II.
The prevalence of overweight and obesity has been increasing in both developed and developing countries. Obesity is related to cardiometabolic risk factors (CMRFs), including insulin resistance, type 2 diabetes, hyperlipidemia, and hypertension, which can lead to cardiometabolic diseases. Moreover, obesity is now one of the greatest drivers of non-alcoholic cirrhosis and different kind of cancers. Weight (kg)/height (m)2 (BMI) has been used since 1970 to classify obesity in adults. One of the main limitations of BMI is the fact that BMI measures excess weight rather than excess fat. Recently, novel anthropometric measures such as a body shape index, hip index, body surface area, vertical trunk circumference, and Visceral adiposity index have been developed to overcome the BMI limitations. These indices are risk factors for both endocrine and non-endocrine disorders, disorders and the potential utility of novel anthropometric indices represents opportunities for early detection and intervention and may have wide-ranging benefits across diverse health settings.
This Research Topic aims:
• To find the association between novel anthropometric indices with cardiometabolic risk factors
• To compare the association between novel anthropometric indices and traditional anthropometric indices with cardiometabolic risk factors We welcome all review, or systematic review, or observational studies, in the assessment of "Association of novel anthropometric indices with cardiometabolic risk factors"
Given the success of the previous collection
Association of Novel Anthropometric Indexes with Metabolic Syndrome and the new advances in the field, we are pleased to announce the launch of Volume II.
The prevalence of overweight and obesity has been increasing in both developed and developing countries. Obesity is related to cardiometabolic risk factors (CMRFs), including insulin resistance, type 2 diabetes, hyperlipidemia, and hypertension, which can lead to cardiometabolic diseases. Moreover, obesity is now one of the greatest drivers of non-alcoholic cirrhosis and different kind of cancers. Weight (kg)/height (m)2 (BMI) has been used since 1970 to classify obesity in adults. One of the main limitations of BMI is the fact that BMI measures excess weight rather than excess fat. Recently, novel anthropometric measures such as a body shape index, hip index, body surface area, vertical trunk circumference, and Visceral adiposity index have been developed to overcome the BMI limitations. These indices are risk factors for both endocrine and non-endocrine disorders, disorders and the potential utility of novel anthropometric indices represents opportunities for early detection and intervention and may have wide-ranging benefits across diverse health settings.
This Research Topic aims:
• To find the association between novel anthropometric indices with cardiometabolic risk factors
• To compare the association between novel anthropometric indices and traditional anthropometric indices with cardiometabolic risk factors We welcome all review, or systematic review, or observational studies, in the assessment of "Association of novel anthropometric indices with cardiometabolic risk factors"